- K-252a
-
- $99.00
-
2026-07-31
- CAS:99533-80-9
- Purity: 98.00%
- Supply Ability: 10g
|
| Product Name: | K-252A | | Synonyms: | (9-alpha,10-beta,12-alpha)-este;[9S,(+)]-2,3,9,10,11,12-Hexahydro-10α-hydroxy-9-methyl-1-oxo-9β,12β-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester;9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-I)(1,6)benzodiazocine-10-carboxylic acid, 2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-, methyl ester, (9alpha,10beta,12alpha)-;9,1-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-I)(1,6)benzodiazocine-10-carboxylic acid, 2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-, methyl ester, (9-alpha,10-beta,12-alpha)-;(9α,10β,12α)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-Methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid Methyl ester;K 252a(SF 2370);2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-0-carboxylicacimethyl;9,1-epoxy-1h-diindolo(1,2,3-fg:3’,2’,1’-kl)pyrrolo(3,4-i)(1,6)benzodiazocine-1 | | CAS: | 99533-80-9 | | MF: | C27H21N3O5 | | MW: | 467.47 | | EINECS: | 640-127-4 | | Product Categories: | antibiotic;Protein Kinase InhibitorsEnzymes, Inhibitors, and Substrates;Antibiotics;Antibiotics A to;Kinase/Phosphatase Biology;Protein Kinases and Phosphatases;Serine/Threonine Kinase Biology;Serine/Threonine Kinase Inhibitors;Protein Kinase;Antibiotics G-MCell Signaling and Neuroscience;Protein Kinase Inhibitors and Related ProductsKinase/Phosphatase Biology | | Mol File: | 99533-80-9.mol |  |
| | K-252A Chemical Properties |
| Melting point | 262-273℃ (decomposition) (methanol ) | | Boiling point | 685.3±55.0 °C(Predicted) | | density | 1.68 | | Fp | 87℃ | | storage temp. | -20°C | | solubility | DMF: 1 mg/mL | | form | Lyophilized solid. | | pka | 11.95±0.40(Predicted) | | color | White or off-white | | biological source | Nonomuraea longicatena | | Stability: | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months. | | InChIKey | KOZFSFOOLUUIGY-SOLYNIJKSA-N | | SMILES | [H][C@]12C[C@](O)(C(=O)OC)[C@](C)(O1)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35 |
| | K-252A Usage And Synthesis |
| Description | K252a is a staurosporine analog isolated from Nocardiopsis sp. soil fungi that inhibits protein kinase (PK) C, PKA, Ca2+/calmodulin-dependent kinase type II, and phosphorylase kinase with IC50 values of 470, 140, 270, and 1.7 nM, respectively. Because it inhibits neurotrophin receptor tyrosine kinases, K252a at 100-500 nM has been used to suppress trophoblast proliferation and increase apoptosis associated with the disruption of mitochondrial functions in cultured choriocarcinoma cells. Recently, K252a has been shown to inhibit PRK1 (IC50 = 3.2 nM in vitro), a PKC-related kinase that phosphorylates histone H3 at threonine 11 and is involved in androgen-dependent gene expression. | | Uses | K-252a is used to inhibit protein kinases involved in cell signaling processes, including CaM kinase; phosphorylase kinase, serine/threonine kinases, Trk. It is used to inhibit the actions of nerve growth factor (NGF) on PC1 2 cells and to inhibit smooth muscle myosin light chain kinase . | | Definition | ChEBI: A organic heterooctacyclic compound that is a potent inhibitor of protein kinase C and is isolated from Nocardiopsis sp K-252a | | Biological Activity | Non-selective protein kinase inhibitor; analog of staurosporine. Inhibits PKC (IC 50 = 32.9 nM), Ca 2+ /calmodulin-stimulated phosphodiesterases (IC 50 = 1.3-2.9 μ M), MLCK (K i = 20 nM) and receptor tyrosine kinases. Inhibits the oncogenic properties of MET; prevents autophosphorylation and activation of downstream effectors (MAPK, Akt). | | Biochem/physiol Actions | Potent inhibitor of various protein kinases including protein kinase A, C, and G. It is is reported to selectively inhibit the actions of nerve growth factor (NGF) on PC1 2 cells and has been shown to inhibit smooth muscle myosin light chain kinase . | | storage | -20°C | | References | [1] HIROSHI KASE. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases[J]. Biochemical and biophysical research communications, 1987, 142 2: Pages 436-440. DOI:10.1016/0006-291x(87)90293-2
[2] YOSHIAKI HASHIMOTO . Potent and preferential inhibition of Ca2+ / calmodulin-dependent protein kinase II by K252a and its derivative, KT5926[J]. Biochemical and biophysical research communications, 1991, 181 1: Pages 423-429. DOI:10.1016/s0006-291x(05)81436-6
[3] M M BERG. K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity.[J]. The Journal of Biological Chemistry, 1992, 267 1: 13-16.
[4] U T RÜEGG G M B. Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases.[J]. Trends in pharmacological sciences, 1989, 10 6: 218-220. DOI:10.1016/0165-6147(89)90263-0
[5] L S CHIN. K252a induces cell cycle arrest and apoptosis by inhibiting Cdc2 and Cdc25c.[J]. Cancer Investigation, 1999, 17 6: 391-395. DOI:10.3109/07357909909021430 |
| | K-252A Preparation Products And Raw materials |
|